CLINICAL_TRIALS
research
· 2026-03-04
Clinical Trial Update: Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial [NA]
Summary
The POSTPOD trial is currently recruiting to evaluate postpartum continuous glucose monitoring for assessing risk of type 2 diabetes in women with a history of …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of California, Los Angeles | Conditions: Gestational Diabetes Mellitus in Pregnancy | NA | Status: RECRUITING